Academic Journals Database
Disseminating quality controlled scientific knowledge

European Journal of Oncology Pharmacy

ISSN: 1783--3914
Publisher: Pharma Publishing & Media Europe


ADD TO MY LIST
 
Physical and chemical stability of cisplatin infusions in PVC containers

Author(s): Graham Sewell
Volume: 4
Issue: 3
Year: 2010
Chemotherapy in the elderly: the critical factors

Author(s): Hans Wildiers
Volume: 4
Issue: 3
Year: 2010
Current situation of cytotoxics preparation in Europe – an ESOP online survey

Author(s): Katharina Perwein
Volume: 4
Issue: 3
Year: 2010
Improving chemotherapy capacity by switching from IV to oral vinorelbine

Author(s): Roger D James | Sandro Barni | Ludwig Fischer von Weikersthal | Andrés Garcia Palomo | Vittorio Gebbia | Olfred Hansen | Andrea Martoni | Peter Meldgaard | Anja Welt | Nathalie Vaissière
Volume: 4
Issue: 3
Year: 2010
Chemotherapy-induced nausea and vomiting: what are the best treatments

Author(s): Steve Williamson
Volume: 4
Issue: 3
Year: 2010
Let this special light shine

Author(s): Klaus Meier
Volume: 4
Issue: 3
Year: 2010
Ninth National Medical Oncology Conference: the latest in medical oncology in Romania

Author(s): Per Hartvig | Eva Honoré
Volume: 4
Issue: 3
Year: 2010
Motivating cancer patients by personality type

Author(s): Günther J Wiedemann
Volume: 4
Issue: 3
Year: 2010
European use of devices supporting safe handling of cytotoxic drugs

Author(s): Ewelina Korczowska | Hanna Jankowiak-Gracz
Volume: 4
Issue: 3
Year: 2010
Iron and erythropoiesis-stimulating agents in anaemia

Author(s): Thomas Rath
Volume: 4
Issue: 3
Year: 2010
Survey of weekend work by ESOP members

Author(s): Kristjan Kongi
Volume: 4
Issue: 3
Year: 2010
SFPO and ESOP recommendations for the practical stability of anticancer drugs

Author(s): Alain Astier | Frédéric Pinguet | Jean Vigneron | SFPO Stability Group members
Volume: 4
Issue: 3
Year: 2010
The practical stability of anticancer drugs: SFPO and ESOP recommendations

Author(s): Alain Astier | Frédéric Pinguet | Jean Vigneron | SFPO Stability Group members
Volume: 4
Issue: 3
Year: 2010
Clinical evaluation of lenograstim use in the Bank of Cyprus Oncology Centre

Author(s): Andri Kouroufexi, MSc | Stavroula Theophanous-Kitiri, MSc | George Polykarpou, MSc
Volume: 5
Issue: 3
Year: 2011
Hospital workers perceptions about nanotechnology

Author(s): Nagwa Ibrahim, PharmD, FAIHQ | Ali Al Zahrani, MD, FRCR | Ashraf Al Alwan, PhD
Volume: 5
Issue: 3
Year: 2011
Setting up a pharmacist-led chemotherapy clinic: a practical guide

Author(s): Carl Booth, BPharm, MPhil, MRPharmS IP
Volume: 5
Issue: 3
Year: 2011
A practical approach to oral tumour therapy

Author(s): Jürgen Barth
Volume: 5
Issue: 3
Year: 2011
Cold water reconstitution of Vidaza® with subsequent refrigerated storage prolongs drug stability

Author(s): Anthony Tutino, RPh | Mei Lai, PhD
Volume: 5
Issue: 3
Year: 2011
DNA repair in cancer therapy: beneficial or harmful

Author(s): Professor Dorothee C Dartsch, PhD
Volume: 5
Issue: 3
Year: 2011
Hope is a good breakfast but a bad supper

Author(s): Klaus Meier, Editor-in-Chief
Volume: 5
Issue: 3
Year: 2011
Preparation of monoclonal antibodies: practice across Europe

Author(s): Mirjam Crul, PharmD, PhD | Ann-Sophie Franki, PharmD, PhD | Kathleen Simons, PharmD
Volume: 5
Issue: 3
Year: 2011
Extravasation of cytotoxics: there is still room for improvement

Author(s): Ursula Pluschnig, MD | Shahla Farokhnia, aHPh | Gunar Stemer, aHPh | Professor Robert M Mader, DSc
Volume: 5
Issue: 3
Year: 2011
Breast cancer irradiation: 2011 update

Author(s): Professor Dr Wolfgang Wagner, MD, PhD
Volume: 5
Issue: 3
Year: 2011
An assessment of the pharmacist’s role in oncology trial management

Author(s): Mikael Daouphars, PharmD, PhD | Ewelina Korczowska, MPharm | Martin Sevec, PharmD
Volume: 5
Issue: 3
Year: 2011
Companion diagnostics and personalised cancer medicine

Author(s): Jan Trøst Jørgensen, MScPharm, PhD | Maria Hersom, BSc
Volume: 5
Issue: 3
Year: 2011
The role of a pharmacist according to patients

Author(s): Anita Waldmann
Volume: 5
Issue: 3
Year: 2011
Announcement

Author(s): EJOP Author
Volume: 5
Issue: 3
Year: 2011
Oncology pharmacists - strong partners in the European movement against cancer

Author(s): Klaus Meier
Volume: 1
Issue: 2
Year: 2007
ESOP News

Author(s): Samo Rožman | Monika Sonc
Volume: 1
Issue: 2
Year: 2007
Pharmacoeconomic considerations in cancer: focus on anaemia

Author(s): Claiborne E Reeder
Volume: 1
Issue: 2
Year: 2007
Targeted treatment: hyperthermia, markers for individual variation and barcodes

Author(s): Jerzy Lazowski
Volume: 1
Issue: 2
Year: 2007
An ounce of prevention: medication error prevention in oncology pharmacy practice

Author(s): Carole R Chambers
Volume: 1
Issue: 2
Year: 2007
ASCO 2007 meeting: advances in the treatment of cancer

Author(s): Günter J Wiedemann | Sabine Thor-Wiedemann
Volume: 1
Issue: 2
Year: 2007
Announcements

Author(s): ESOP
Volume: 1
Issue: 2
Year: 2007
Liposomal cisplatin: Lipoplatin

Author(s): Robert Terkola
Volume: 1
Issue: 2
Year: 2007
National News

Author(s): Jerzy Lazowski | Samo Rožman | Monika Sonc
Volume: 1
Issue: 2
Year: 2007
Management of breast cancer in older women: tailoring adjuvant therapy

Author(s): Günter J Wiedemann | Wolfgang Wagner
Volume: 1
Issue: 2
Year: 2007
External contamination of packaging by anticancer drugs: a recurrent problem

Author(s): Alain Astier | Stavroula Kitiri
Volume: 1
Issue: 2
Year: 2007
Supportive care: emesis, constipation and diarrhoea

Author(s): Per Hartvig | Eva Honoré
Volume: 1
Issue: 2
Year: 2007
Implementation of a CPOE system for cytotoxic prescriptions using CYPRO

Author(s): Silke Braband
Volume: 1
Issue: 2
Year: 2007
Adverse health effects in personnel handling cytotoxic drugs

Author(s): Per Hartvig | Eva Honoré
Volume: 1
Issue: 2
Year: 2007
Combined radiochemotherapy – the state of the art - part one

Author(s): Afshin Radmard
Volume: 1
Issue: 2
Year: 2007
Placebo: money for nothing?

Author(s): Sabine Thor-Wiedemann | Günther J Wiedemann
Volume: 2
Issue: 2
Year: 2008
Clinical case study: unexpected toxicities in colorectal cancer treatment

Author(s): Alain Astier
Volume: 2
Issue: 2
Year: 2008
Important advances in haematology

Author(s): Günter J Wiedemann | Wolfgang Wagner
Volume: 2
Issue: 2
Year: 2008
The role of European oncology pharmacists in patient education in CML treatment

Author(s): Alain Astier
Volume: 3
Issue: 2
Year: 2009
Research and development: a way forward for oncology pharmacy

Author(s): Per Hartvig-Honoré
Volume: 3
Issue: 2
Year: 2009
Recent clinical studies with uridine cream

Author(s): Irena Netíková | Agnes Pestka | Jürgen Barth
Volume: 3
Issue: 2
Year: 2009
Everolimus, a further step in ‘targeted’ antineoplastic therapy?

Author(s): Wilfried Büchler
Volume: 3
Issue: 2
Year: 2009
Bone metastases and treatment by irradiation

Author(s): Jean-Leon Lagrange
Volume: 3
Issue: 2
Year: 2009
The treatment of glioblastoma – state of the art

Author(s): Wolfgang Wagner | J Hartlapp | Günther Wiedemann | MG Krukemeyer
Volume: 3
Issue: 2
Year: 2009
Standards, like everything else, develop because we need them

Author(s): Klaus Meier
Volume: 3
Issue: 2
Year: 2009
ESOP News

Author(s): Irena Netíková
Volume: 3
Issue: 2
Year: 2009
Drug interactions in cancer treatment: a potential role for oncology pharmacists

Author(s): Suphat Subongkot
Volume: 3
Issue: 2
Year: 2009
Determinants of attendance at cervical cancer screening and HPV vaccination clinics

Author(s): Hans-Robert Metelmann
Volume: 3
Issue: 2
Year: 2009
Neurotoxicity, a common side effect of cytotoxic therapy – how to protect the patient

Author(s): Irena Netíková
Volume: 3
Issue: 2
Year: 2009
The Infostab/Stabilis website: a tool for oncology pharmacists

Author(s): Jean Vigneron
Volume: 3
Issue: 2
Year: 2009
Comparison of devices supporting safe handling of cytotoxic drugs

Author(s): Ewelina Korczowska
Volume: 3
Issue: 2
Year: 2009
The American way of funding for cancer research saves lives. Where are the Europeans?

Author(s): Günther J Wiedemann | Wolfgang Wagner
Volume: 3
Issue: 2
Year: 2009
Re-escalation of sunitinib dose following dose reduction for thrombocytopenia

Author(s): Charlotte Benson | Lynda Pyle | James Larkin
Volume: 3
Issue: 2
Year: 2009
Vertical shock tests with safety packaging materials for cytotoxic drugs

Author(s): Wolfgang Teichmann
Volume: 2
Issue: 2
Year: 2008
Allergic reactions to oxaliplatin therapy – an overview

Author(s): Goentje-Gesine Marquardt | Detlev Brinkmann
Volume: 2
Issue: 2
Year: 2008
Improving the care of anorexia-cachexia patients

Author(s): Inga Andrew
Volume: 2
Issue: 2
Year: 2008
Tumour lysis syndrome – prevention and treatment

Author(s): Michael Hoeckel
Volume: 2
Issue: 2
Year: 2008
The new era of trabectedin in soft tissue sarcomas

Author(s): Axel Le Cesne
Volume: 2
Issue: 2
Year: 2008
National News

Author(s): Eva Honoré | Jerzy Lazowski
Volume: 2
Issue: 2
Year: 2008
Meeting Report: Pan-Hellenic hospital pharmacists seminar in Cairo

Author(s): Ioanna Saratsiotou
Volume: 2
Issue: 2
Year: 2008
Standardised labels for cytotoxics

Author(s): Monique Ackermann
Volume: 2
Issue: 2
Year: 2008
Positron emission tomography and its application to clinical oncology

Author(s): Per Hartvig
Volume: 2
Issue: 2
Year: 2008
Klaus Meier appointed to the board of ECCO

Author(s): Klaus Meier
Volume: 2
Issue: 2
Year: 2008
Masterclass in oncology pharmacy practice

Author(s): Nils Kallberg | Xavier Armoiry | Visnja Kopecki
Volume: 2
Issue: 2
Year: 2008
Pharmacoeconomic trends in Germany: searching for evidence?

Author(s): J-Matthias Graf von der Schulenburg
Volume: 2
Issue: 2
Year: 2008
Models of tumourigenesis and their relevance for tumour pharmacology

Author(s): Robert M Mader
Volume: 2
Issue: 2
Year: 2008
Cisplatin combined with other drugs - how drugs affect one another and the patient

Author(s): Mirha Jusovic
Volume: 2
Issue: 2
Year: 2008
Complementary and alternative medicine in cancer patients

Author(s): Jens Büntzel | Ralph Mücke | Frank Bruns | Oliver Micke
Volume: 2
Issue: 2
Year: 2008
ASCO 2008 congress: many new drugs against advanced cancer

Author(s): Günther J Wiedemann | Wolfgang Wagner
Volume: 2
Issue: 2
Year: 2008
Drug treatment of epilepsy in people with brain tumours

Author(s): Simon Kerrigan
Volume: 4
Issue: 2
Year: 2010
Emerging targets for the modulation of apoptosis resistance in anticancer treatment

Author(s): Verena Jendrossek
Volume: 4
Issue: 2
Year: 2010
Pharmacometrics in cytotoxic drug dosing – a population-based approach

Author(s): Per Hartvig | Mikkel Krogh-Madsen
Volume: 4
Issue: 2
Year: 2010
Association study of rs6983267 at 8q24 with prostate cancer in the Greek population

Author(s): Nikolaos Drakoulis | Amalia Papanikolopoulou | Olfert Landt | Martin Reczko
Volume: 4
Issue: 2
Year: 2010
Parenteral nutrition in oncology

Author(s): Alessandro Laviano | Dina Ljubas Kelecic | Filippo Rossi Fanelli
Volume: 4
Issue: 2
Year: 2010
Difficult decisions in the cost-effectiveness analysis of new cancer treatments

Author(s): Pax HB Willemse | Vivianne CG Tjan-Heijnen
Volume: 4
Issue: 2
Year: 2010
The role of the oncology pharmacist in the therapeutic decision-making process

Author(s): Samuel Limat | Virginie Nerich
Volume: 4
Issue: 2
Year: 2010
4th Masterclass in oncology pharmacy

Author(s): Andreja Eberl
Volume: 4
Issue: 2
Year: 2010
History leads us – the future defines us

Author(s): Klaus Meier
Volume: 4
Issue: 2
Year: 2010
EJOP Industry News

Author(s): EJOP Author
Volume: 4
Issue: 2
Year: 2010
Modelling the net resource implications and budget impact of using generic docetaxel instead of branded docetaxel in Spain

Author(s): Erikas Sladkevicius | David López | Julian F Guest
Volume: 4
Issue: 2
Year: 2010
Individualisation of cancer treatment by pharmacogenetics

Author(s): Henk-Jan Guchelaar | Per Hartvig
Volume: 4
Issue: 2
Year: 2010
How radiotherapy can be used as a new approach in breast cancer

Author(s): Günther J Wiedemann | Wolfgang Wagner
Volume: 4
Issue: 2
Year: 2010
2010 ASCO Annual Meeting: progress in difficult-to-treat cancers

Author(s): Günther J Wiedemann | Wolfgang Wagner
Volume: 4
Issue: 2
Year: 2010
Different demands, common understanding: the roles of physicians and pharmacists

Author(s): Ralf Klask | Goentje-Gesine
Volume: 4
Issue: 2
Year: 2010
Erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anaemia

Author(s): Phebe Si, BScPharm (Hons) | Alexandre Chan PharmD, Assistant Professor
Volume: 5
Issue: 2
Year: 2011
Cytotoxics in the pipeline: carrier-mediated anticancer agents in development

Author(s): Suphat Subongkot, PharmD, BCPS, BCOP
Volume: 5
Issue: 2
Year: 2011
Systematic reviews of resection of metastases in metastatic colorectal cancer

Author(s): Meredith Edwards, BMedSci, MBBS | Zhongyun Zhao, PhD | Shkun Chadda, BSc, MSc | Beth Barber, PhD
Volume: 5
Issue: 2
Year: 2011
Implementing quality in the preparation of cytotoxic drugs

Author(s): Jeff Koundakjian, BPharm, MRPharmS
Volume: 5
Issue: 2
Year: 2011
Germany tightens controls on pharmaceutical prices

Author(s): EJOP Author
Volume: 5
Issue: 2
Year: 2011
Improving the safety performance of the Onco-Safe® system

Author(s): Dr Werner Kittlaus
Volume: 5
Issue: 2
Year: 2011
An Italian model to evaluate appropriateness and effectiveness of drugs

Author(s): Angelo C Palozzo, PharmD
Volume: 5
Issue: 2
Year: 2011
Which role shall the pharmacists play in oncology

Author(s): Klaus Meier, Editor-in-Chief
Volume: 5
Issue: 2
Year: 2011
Safe handling of oral chemotherapeutic agents: a European perspective

Author(s): Klaus Meier, PharmD | Niesha Griffith, MS | Susan Goodin, PharmD | et al
Volume: 5
Issue: 2
Year: 2011
2011 EPAAC Open Forum

Author(s): Professor Per Hartvig-Honoré, PharmD, PhD
Volume: 5
Issue: 2
Year: 2011
ASCO 2011: setting new standards in malignant melanoma and myelofibrosis

Author(s): Gertrud Lenzen, MD
Volume: 5
Issue: 2
Year: 2011
35th ESMO Congress report: recent advances in cancer treatment

Author(s): Svetlana Jezdic, MD
Volume: 5
Issue: 2
Year: 2011
Chemotherapy dosing in obese patients: the real evidence

Author(s): Nagwa Ibrahim
Volume: 5
Issue: 1
Year: 2011
Procedures aid the oncology pharmacy in the preparation and supply of anticancer drugs

Author(s): Graziella Sassi
Volume: 5
Issue: 1
Year: 2011
Drug interactions in oncology: the impact on cancer care

Author(s): Suphat Subongkot
Volume: 5
Issue: 1
Year: 2011
Fixed-dose versus patient-specific dosing of anticancer agents

Author(s): Bruce Burnett
Volume: 5
Issue: 1
Year: 2011
Case reports in oncology pharmacy

Author(s): Dorothee Dartsch
Volume: 1
Issue: 1
Year: 2007
Patient demands are customer demands – they are important

Author(s): Klaus Meier
Volume: 1
Issue: 1
Year: 2007
The stability of anticancer drugs

Author(s): Alain Astier
Volume: 1
Issue: 1
Year: 2007
Lapatinib ditosylate (Tykerb)

Author(s): Robert Terkola
Volume: 1
Issue: 1
Year: 2007
News from the Czech Republic

Author(s): Irena Netikova
Volume: 1
Issue: 1
Year: 2007
Workshop in Slovenia: patient safety in oncology

Author(s): Monika Sonc
Volume: 1
Issue: 1
Year: 2007
7th annual meeting of Polish oncology pharmacists

Author(s): Jerzy Lazowski
Volume: 1
Issue: 1
Year: 2007
Master Class in “Quality Standards in Oncology Pharmacy”

Author(s): Per Hartvig
Volume: 1
Issue: 1
Year: 2007
Necessity is the mother of invention

Author(s): Klaus Meier
Volume: 1
Issue: 1
Year: 2007
Advances and challenges in the treatment of breast cancer

Author(s): Guenther J Wiedemann | Sabine Thor-Wiedemann
Volume: 1
Issue: 1
Year: 2007
Advances in the treatment of kidney, head and neck cancers

Author(s): Guenther J Wiedemann | Sabine Thor-Wiedemann
Volume: 1
Issue: 1
Year: 2007
Advances in the treatment of blood cancer

Author(s): Guenther J Wiedemann | Sabine Thor-Wiedemann
Volume: 1
Issue: 1
Year: 2007
What's new?

Author(s): Guenther J Wiedemann | Sabine Thor-Wiedemann
Volume: 1
Issue: 1
Year: 2007
Third Polish-German conference on oncology pharmacy

Author(s): Julia Bogumiła Sobkowiak
Volume: 1
Issue: 1
Year: 2007
Supportive care: alleviating fatigue and pain

Author(s): Per Hartvig | Eva Honoré
Volume: 1
Issue: 1
Year: 2007
A good standard of contributions at the SFPO

Author(s): Frederic Pinguet
Volume: 2
Issue: 1
Year: 2008
New approaches, new treatments

Author(s): Wolfgang Wagner
Volume: 2
Issue: 1
Year: 2008
Pictures of life beyond cancer

Author(s): Jenny Bryan
Volume: 2
Issue: 1
Year: 2008
Because there is a need

Author(s): Klaus Meier
Volume: 2
Issue: 1
Year: 2008
Dasatinib in the treatment of chronic myeloid leukaemia

Author(s): Jerzy Lazowski
Volume: 2
Issue: 1
Year: 2008
Dispensing of oral chemotherapy in the community: a viability assessment in the UK

Author(s): Libby Hardy | Jeff Koundakjian
Volume: 2
Issue: 1
Year: 2008
Current thinking in antifungal prophylaxis

Author(s): Christina T Rieger | Helmut Ostermann
Volume: 2
Issue: 1
Year: 2008
8th Annual meeting of Polish oncology pharmacists

Author(s): Jerzy Lazowski
Volume: 2
Issue: 1
Year: 2008
Highlights of the NZW-Süd oncology meeting in Ravensburg, Germany

Author(s): Günter J Wiedemann | Sabine Thor-Wiedemann
Volume: 2
Issue: 1
Year: 2008
Greek pharmacists visit the Bank of Cyprus Oncology Centre

Author(s): Stavroula Theophanous-Kitiri
Volume: 2
Issue: 1
Year: 2008
Spillages and occupational exposure to cytotoxic drugs in an oncology centre

Author(s): Stavroula Theophanous-Kitiri | Elpidoforos S Soteriades
Volume: 2
Issue: 1
Year: 2008
Psychological support of quality of life in cancer patients

Author(s): Barbara Czerska
Volume: 2
Issue: 1
Year: 2008
Glucarpidase: a method of rescue from high dose methotrexate

Author(s): S Laghouati | S Demirdjian | G Vassal
Volume: 2
Issue: 1
Year: 2008
Supportive care: nutrition problems, alopecia and mucositis

Author(s): Per Hartvig | Eva Honoré
Volume: 2
Issue: 1
Year: 2008
Combined radiochemotherapy – the state of the art - part two

Author(s): Wolfgang Wagner
Volume: 2
Issue: 1
Year: 2008
Non-compliance in cancer treatment

Author(s): Lukasz Lapinski
Volume: 3
Issue: 1
Year: 2009
Best use of targeted agents for the treatment of advanced renal cell carcinoma

Author(s): Sylvie Négrier
Volume: 3
Issue: 1
Year: 2009
11th Annual Symposium of the British Oncology Pharmacy Association

Author(s): Janis Smy
Volume: 3
Issue: 1
Year: 2009
Radiotherapy of neuroendocrine gastroenteropancreatic tumours: new principles

Author(s): Aseel Cherif
Volume: 3
Issue: 1
Year: 2009
Nuclear medicine needs radiopharmacists!

Author(s): Alistair M Millar
Volume: 3
Issue: 1
Year: 2009
Joint venture in continuing education

Author(s): Geoff Saunders
Volume: 3
Issue: 1
Year: 2009
Our capability needs a goal – patients need our competence

Author(s): Klaus Meier
Volume: 3
Issue: 1
Year: 2009
ESOP News

Author(s): Per Hartvig-Honoré
Volume: 3
Issue: 1
Year: 2009
Pharmaceutical oncology standards in Europe

Author(s): Per Hartvig-Honoré
Volume: 3
Issue: 1
Year: 2009
Business as usual and some surprises

Author(s): Günther J Wiedemann | Wolfgang Wagner
Volume: 3
Issue: 1
Year: 2009
Europa Uomo in collaboration with ESOP

Author(s): Louis Denis
Volume: 3
Issue: 1
Year: 2009
Clinically relevant news from the ASH 2009 meeting

Author(s): Günther J Wiedemann | Andreas Keßler | Gerhard Fischer | Wolfgang Wagner
Volume: 4
Issue: 1
Year: 2010
Highlights of the Joint ECCO 15–34th ESMO Multidisciplinary Congress

Author(s): M Garassino | Branko Zakotnik
Volume: 4
Issue: 1
Year: 2010
Asian activities in oncology pharmacy

Author(s): Kamonsak Reungjarearnrung
Volume: 4
Issue: 1
Year: 2010
Third masterclass in oncology pharmacy

Author(s): Ioanna Saratsiotou
Volume: 4
Issue: 1
Year: 2010
10th Annual Meeting of Polish oncology pharmacists

Author(s): Jerzy Lazowski
Volume: 4
Issue: 1
Year: 2010
Polish-German conference on oncology pharmacy

Author(s): Jerzy Lazowski
Volume: 4
Issue: 1
Year: 2010
12th Annual Symposium of the British Oncology Pharmacy Association

Author(s): Janis Smy
Volume: 4
Issue: 1
Year: 2010
Medical devices for safe handling of cytotoxic drugs

Author(s): Pascal Odou | Damien Lannoy | Bertrand Decaudin | Nicolas Simon
Volume: 4
Issue: 1
Year: 2010
Contamination from handling cytotoxic agents

Author(s): Jean François Latour
Volume: 4
Issue: 1
Year: 2010
Everything changes, nothing stays the same

Author(s): Klaus Meier
Volume: 4
Issue: 1
Year: 2010
Quality Standards for the Oncology Pharmacy Service

Author(s): Andreja Eberl | Monika Sonc
Volume: 4
Issue: 1
Year: 2010
The development of oncology pharmacy

Author(s): Robert Terkola | Vesna Pavlica | Irena Netíková | Mari Kand | Linda Krolop | Ioanna Saratsiotou | Mónika Kis Szölgyöémi | Franca Goffredo | María José Tamés | Ahmet S Bosnak
Volume: 4
Issue: 1
Year: 2010
New horizons in cytotoxic therapeutic drug monitoring

Author(s): Per Hartvig-Honoré | Mikkel Krogh-Madsen
Volume: 4
Issue: 1
Year: 2010
An introduction to mucositis

Author(s): Jürgen Barth
Volume: 4
Issue: 1
Year: 2010
Novel oral anticancer drugs: perspectives and limitations

Author(s): Hans-Peter Lipp
Volume: 5
Issue: 1
Year: 2011
Molecular imaging using PET/CT in oncology: current and future developments

Author(s): Harshad Kulkarni | Grit Berger | Richard P Baum
Volume: 5
Issue: 1
Year: 2011
Paediatric oncology: a primer

Author(s): John T Wiernikowski
Volume: 5
Issue: 1
Year: 2011
EJOP is recognised as the leading publication in oncology pharmacy in Europe

Author(s): EJHP Author
Volume: 5
Issue: 1
Year: 2011
Working towards a better future for our patients

Author(s): Klaus Meier
Volume: 5
Issue: 1
Year: 2011
Establishing cost-effectiveness of genetic targeting of cancer therapies

Author(s): Valesca P Retèl | EJTh Rutgers | MA Joore | WH van Harten
Volume: 5
Issue: 1
Year: 2011
Standardised labels for cytotoxics

Author(s): Monique Ackermann
Volume: 5
Issue: 1
Year: 2011
13th Annual Symposium of the British Oncology Pharmacy Association

Author(s): Janis Smy
Volume: 5
Issue: 1
Year: 2011
ESOP News

Author(s): Per Hartvig | Eva Honoré
Volume: 2
Issue: 1
Year: 2008
National News

Author(s): Maria José Tamés | Vesna Pavlica
Volume: 2
Issue: 1
Year: 2008
Great TEFL Deals